MESO

Mesoblast Limited - American Depositary Shares (MESO)

About Mesoblast Limited - American Depositary Shares (MESO)

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Details

Daily high
$15.48
Daily low
$15.11
Price at open
$15.27
52 Week High
$21.50
52 Week Low
$13.05
Market cap
2.0B
Dividend yield
-
Volume
100,375
Avg. volume
194,850
P/E ratio
-33.96

Mesoblast Limited - American Depositary Shares News

Details

Daily high
$15.48
Daily low
$15.11
Price at open
$15.27
52 Week High
$21.50
52 Week Low
$13.05
Market cap
2.0B
Dividend yield
-
Volume
100,375
Avg. volume
194,850
P/E ratio
-33.96